These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9495863)

  • 1. Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties.
    Meyer EM; Tay ET; Zoltewicz JA; Meyers C; King MA; Papke RL; De Fiebre CM
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1026-32. PubMed ID: 9495863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
    de Fiebre CM; Meyer EM; Henry JC; Muraskin SI; Kem WR; Papke RL
    Mol Pharmacol; 1995 Jan; 47(1):164-71. PubMed ID: 7838125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
    Meyer EM; Kuryatov A; Gerzanich V; Lindstrom J; Papke RL
    J Pharmacol Exp Ther; 1998 Dec; 287(3):918-25. PubMed ID: 9864273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.
    Kem WR; Mahnir VM; Papke RL; Lingle CJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative levels of cytoprotection produced by analogs of choline and the role of alpha7-nicotinic acetylcholine receptors.
    Jonnala RR; Graham JH; Terry AV; Beach JW; Young JA; Buccafusco JJ
    Synapse; 2003 Mar; 47(4):262-9. PubMed ID: 12539199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects at a distance in alpha 7 nAChR selective agonists: benzylidene substitutions that regulate potency and efficacy.
    Papke RL; Meyer EM; Lavieri S; Bollampally SR; Papke TA; Horenstein NA; Itoh Y; Porter Papke JK
    Neuropharmacology; 2004 Jun; 46(7):1023-38. PubMed ID: 15081799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
    Reuben M; Louis M; Clarke PB
    Br J Pharmacol; 1998 Nov; 125(6):1218-27. PubMed ID: 9863650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of anabasine on catecholamine secretion from the perfused rat adrenal medulla.
    Hong SP; Jeong MG; Lim DY
    J Cardiol; 2007 Dec; 50(6):351-62. PubMed ID: 18186309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats.
    Skoubis PD; Hradil V; Chin CL; Luo Y; Fox GB; McGaraughty S
    Neuroscience; 2006; 137(2):583-91. PubMed ID: 16289887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner.
    Meyer EM; Tay ET; Papke RL; Meyers C; Huang GL; de Fiebre CM
    Brain Res; 1997 Sep; 768(1-2):49-56. PubMed ID: 9369300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective and antiamnesic effect of donepezil, a nicotinic acetylcholine-receptor activator, on rats with concussive mild traumatic brain injury.
    Fujiki M; Kubo T; Kamida T; Sugita K; Hikawa T; Abe T; Ishii K; Kobayashi H
    J Clin Neurosci; 2008 Jul; 15(7):791-6. PubMed ID: 18407501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380.
    Mogg AJ; Jones FA; Pullar IA; Sharples CG; Wonnacott S
    Neuropharmacology; 2004 Nov; 47(6):848-59. PubMed ID: 15527819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iptakalim inhibits nicotinic acetylcholine receptor-mediated currents in dopamine neurons acutely dissociated from rat substantia nigra pars compacta.
    Hu J; DeChon J; Yan KC; Liu Q; Hu G; Wu J
    Neurosci Lett; 2006 Jul; 403(1-2):57-62. PubMed ID: 16730119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.
    Gronier B; Rasmussen K
    Br J Pharmacol; 1998 Jun; 124(3):455-64. PubMed ID: 9647468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist actions of neonicotinoids on nicotinic acetylcholine receptors expressed by cockroach neurons.
    Tan J; Galligan JJ; Hollingworth RM
    Neurotoxicology; 2007 Jul; 28(4):829-42. PubMed ID: 17561262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.
    Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Cosford ND
    Brain Res; 2008 Oct; 1234():16-24. PubMed ID: 18692487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor.
    Machu TK; Hamilton ME; Frye TF; Shanklin CL; Harris MC; Sun H; Tenner TE; Soti FS; Kem WR
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1112-9. PubMed ID: 11714901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitation of glutamate release by nicotine involves the activation of a Ca2+/calmodulin signaling pathway in rat prefrontal cortex nerve terminals.
    Wang BW; Liao WN; Chang CT; Wang SJ
    Synapse; 2006 Jun; 59(8):491-501. PubMed ID: 16565963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strychnine, but not PMBA, inhibits neuronal nicotinic acetylcholine receptors expressed by rabbit retinal ganglion cells.
    Renna JM; Strang CE; Amthor FR; Keyser KT
    Vis Neurosci; 2007; 24(4):503-11. PubMed ID: 17900376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.